Today’s edition of BioStock Live features the Swedish medtech company Acarix. CEO Per Persson tells us more about the company and its product, the CADScor System – a diagnostic device for healthcare professionals investigating patients who suffer from symptoms related to coronary artery disease. Acarix has recently received market approval for CADScor in the US, and the CEO expects a news-intensive 2021.
Watch the presentation here at 10:00: https://www.biostock.se/2021/04/biostock-live-with-acarix/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se